XETRA - Delayed Quote EUR

Viatris Inc. (VIA.DE)

10.56 -0.01 (-0.14%)
As of 2:48 PM GMT+2. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
15,426,900.00
15,426,900.00
16,262,700.00
17,886,300.00
11,946,000.00
Cost of Revenue
8,988,300.00
8,988,300.00
9,765,700.00
12,310,800.00
8,149,300.00
Gross Profit
6,438,600.00
6,438,600.00
6,497,000.00
5,575,500.00
3,796,700.00
Operating Expense
5,455,300.00
5,455,300.00
4,841,300.00
5,210,200.00
3,857,200.00
Operating Income
983,300.00
983,300.00
1,655,700.00
365,300.00
-60,500.00
Net Non Operating Interest Income Expense
-573,100.00
-573,100.00
-592,400.00
-636,200.00
-497,800.00
Other Income Expense
-207,300.00
-207,300.00
1,749,900.00
-393,500.00
-162,900.00
Pretax Income
202,900.00
202,900.00
2,813,200.00
-664,400.00
-721,200.00
Tax Provision
148,200.00
148,200.00
734,600.00
604,700.00
-51,300.00
Net Income Common Stockholders
54,700.00
54,700.00
2,078,600.00
-1,269,100.00
-669,900.00
Diluted NI Available to Com Stockholders
54,700.00
54,700.00
2,078,600.00
-1,269,100.00
-669,900.00
Basic EPS
0.05
0.05
1.71
-1.05
-1.11
Diluted EPS
0.05
0.05
1.71
-1.05
-1.11
Basic Average Shares
1,200,300.00
1,200,300.00
1,212,100.00
1,208,800.00
601,200.00
Diluted Average Shares
1,206,900.00
1,206,900.00
1,217,400.00
1,208,800.00
601,200.00
Total Operating Income as Reported
766,200.00
766,200.00
1,614,900.00
-34,000.00
-210,800.00
Total Expenses
14,443,600.00
14,443,600.00
14,607,000.00
17,521,000.00
12,006,500.00
Net Income from Continuing & Discontinued Operation
54,700.00
54,700.00
2,078,600.00
-1,269,100.00
-669,900.00
Normalized Income
226,209.00
226,209.00
2,108,746.05
-977,611.00
-530,271.30
Interest Expense
573,100.00
573,100.00
592,400.00
636,200.00
497,800.00
Net Interest Income
-573,100.00
-573,100.00
-592,400.00
-636,200.00
-497,800.00
EBIT
776,000.00
776,000.00
3,405,600.00
-28,200.00
-223,400.00
EBITDA
3,516,500.00
3,516,500.00
6,433,200.00
4,478,300.00
1,992,700.00
Reconciled Cost of Revenue
8,988,300.00
8,988,300.00
9,765,700.00
12,310,800.00
8,149,300.00
Reconciled Depreciation
2,740,500.00
2,740,500.00
3,027,600.00
4,506,500.00
2,216,100.00
Net Income from Continuing Operation Net Minority Interest
54,700.00
54,700.00
2,078,600.00
-1,269,100.00
-669,900.00
Total Unusual Items Excluding Goodwill
-217,100.00
-217,100.00
-40,800.00
-399,300.00
-150,300.00
Total Unusual Items
-217,100.00
-217,100.00
-40,800.00
-399,300.00
-150,300.00
Normalized EBITDA
3,733,600.00
3,733,600.00
6,474,000.00
4,877,600.00
2,143,000.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-45,591.00
-45,591.00
-10,653.95
-107,811.00
-10,671.30
12/31/2020 - 12/13/2007

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

27N0.F Cannovum Cannabis AG
2.3000
0.00%
 
SBX.F SynBiotic SE
10.30
0.00%
 
DMP.DE Dermapharm Holding SE
32.65
-0.15%
 
RX.V BioSyent Inc.
8.50
+1.19%
 
INNO.CN InnoCan Pharma Corporation
0.2800
+3.70%
 
DN.TO Delta 9 Cannabis Inc.
0.0250
+25.00%
 
TEVA Teva Pharmaceutical Industries Limited
12.89
+0.04%
 
TLRY Tilray Brands, Inc.
1.7450
+1.45%
 
WEED.TO Canopy Growth Corporation
10.77
-0.19%
 
CGC Canopy Growth Corporation
7.88
+0.32%